Healthcare
| Company | Ticker | Margin |  Valuation |
|---|---|---|---|
| West Pharmaceutical Services Inc. | WST |
Overvalued by 33%
|
$50.11 |
| Align Technology, Inc. | ALGN |
Overvalued by 47%
|
$49.99 |
| CPEX Pharmaceuticals, Inc. | CPEX |
Undervalued by 78%
|
$48.76 |
| Valeant Pharmaceuticals International | VRX |
Undervalued by 80%
|
$48.63 |
| Valeant Pharmaceuticals Intl Inc | VRX |
Undervalued by 37%
|
$48.63 |
| Exactech, Inc. | EXAC |
Undervalued by 72%
|
$48.13 |
| Hologic, Inc. | HOLX |
Undervalued by 24%
|
$47.48 |
| Charles River Laboratories | CRL |
Overvalued by 41%
|
$47.47 |
| Mindray Medical International Limited | MR |
Undervalued by 70%
|
$47.35 |
| AMN Healthcare Services, Inc. | AHS |
Undervalued by 37%
|
$47.34 |
| Genzyme Corporation | GENZ |
Overvalued by 38%
|
$47.17 |
| Baxter International Inc. | BAX |
Overvalued by 1%
|
$47.13 |
| Matrixx Initiatives, Inc. | MTXX |
Undervalued by 433%
|
$46.72 |
| Salix Pharmaceuticals, Ltd. | SLXP |
Overvalued by 73%
|
$46.02 |
| Life Sciences Research, Inc. | LSR |
Undervalued by 438%
|
$45.78 |
| Haemonetics Corporation | HAE |
Undervalued by 22%
|
$45.08 |
| Alere Inc | ALR |
Undervalued by 2%
|
$44.27 |
| Anika Therapeutics, Inc. | ANIK |
Overvalued by 7%
|
$44.24 |
| II-VI, Inc. | IIVI |
Undervalued by 94%
|
$44.11 |
| Lincare Holdings Inc. | LNCR |
Undervalued by 4%
|
$43.25 |
| Mylan Inc. | MYL |
Undervalued by 4%
|
$43.25 |
| Genomic Health, Inc. | GHDX |
Undervalued by 51%
|
$42.69 |
| Jiangbo Pharmaceuticals, Inc. | JGBO |
Undervalued by 9,999%
|
$42.52 |
| Cantel Medical Corp. | CMN |
Overvalued by 46%
|
$42.25 |
| RehabCare Group, Inc. | RHB |
Undervalued by 12%
|
$42.23 |